Objectives: High-grade, poorly differentiated angiosarcoma is a rare, aggressive malignant neoplasm, comprising 1%-2% of head and neck sarcomas. Diagnosis is often delayed, due to its putatively innocuous clinical appearance combined with the unusual morphology. We report here a case of high-grade angiosarcoma in an elderly patient mimicking clinically and radiologically a benign cyst, and histiocyte-like cells on the morphology. Methods: The specimen was fixed in 10% buffered formalin solution and embedded in paraffin using routine procedures. Dewaxed paraffin sections were stained with hematoxylin and eosin. Immunoperoxidase stains were performed on the deparaffinized sections using an avidin-biotin-peroxidase complex. Results: The surgical biopsy revealed histiocytic-like cells characterized by medium to large round nuclei, vesicular chromatin, small nucleoli, abundant eosinophilic cytoplasm, and ill-defined cell borders. These cells are intermixed with chronic inflammatory cells and surrounded by the peripheral cuff of lymphoid cells. Rare multinucleated and multilobulated cells were also identified. No vasoformative structures were identified. On the basis of histomorphology alone, a follicular dendritic sarcoma or other histiocytic sarcoma was considered; however, immunohistochemical stains (CD35, CD23, CD21) were negative in the malignant population, as were the melanoma markers (S100, HMB-45, SOX10, and Melan A) and epithelial markers (EMA, AE1/AE3, CK5/6, CK8/18, and p40); B-and T-cell markers stained only admixed mature lymphocytes. In contrast to these negative results, immunohistochemical studies provided compelling evidence of endothelial differentiation showing positive expression of numerous vascular markers, including CD31, CD34, D2-40, ERG, and factor VIII. A diagnosis of poorly differentiated angiosarcoma was rendered. Conclusion: High-grade, poorly differentiated angiosarcoma has dismal prognosis with high risk of recurrences. Knowledge of its atypical clinical and radiological presentation, as well as awareness of its unusual morphology of histiocyte-like cells can lead to the early diagnosis and prompt treatment.
Improving the Quality of Bone Marrow Biopsy in a Pediatric Hospital
Emory University School of Medicine, Atlanta, GA Objectives: Bone marrow aspirate and biopsy is a common procedure for the initial evaluation or follow-up of children with hematologic disorders or for disease staging for patients with solid tumors. Obtaining quality bone marrow aspirate samples with adequate spicules and proper handling of the specimens is important for diagnosis and ancillary testing, especially important to obtain non-hemodiluted aspirate for minimal residual disease study. We implemented a process that has improved the quality of the procedure. Methods: In our large volume program, with > 400 new pediatric oncology cases annually, there is heterogeneity of bedside providers performing procedures. Our lab partnered with the clinical team to provide a bedside marrow service to ensure realtime feedback to ensure spiculated bone marrow aspirates are obtained. We developed a new institutional protocol for collection and handling of specimens based on International Council for Standardization in Haematology guidelines and needed testing for each diagnostic group. In addition we provided training to the lab staff and clinical providers to evaluate in real time for spicules. Performance metrics have been established and are reviewed regularly to address barriers and challenges. Results: In the first year of implementation, bedside marrow assist was available in 547 cases. The quality of the bone marrow biopsies as judged by the rate of spiculated bone marrow aspirates has improved significantly. Spicules noted on microscopic review have increased from less than 50% pre-implementation to average more than 80% in the initial year after implementation of the procedure. Conclusion: Providing bedside bone marrow quality assessment has been valuable in improving the quality of specimens. Additional value in other areas, include sample flow into a functional biorepository, providing the assistance in trainees in performing the procedure, opportunities to improve other quality measures such as clotted marrow, quality of chromosome analysis, and improving the accuracy of test ordering.
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Application of Lean Six Sigma Methodologies in the Laboratory to Drive a Reduction in Corrected Reports
Michelle M Havinga, BS, MLS(ASCP)CM; Accumen, San Diego, CA
Introduction: A 750-bed hospital laboratory was facing challenges meeting their quality metric goal for corrected reports. This problem led to a process improvement (PI) being implemented, which consisted of the application of Lean Six Sigma methodologies. Prior to the PI, the
